Vinci Compass Investments Ltd. (VINP)

Theseus Pharmaceuticals Revenue

Vinci Compass Investments had revenue of 234.72M BRL in the quarter ending March 31, 2025, with 115.17% growth. This brings the company's revenue in the last twelve months to 726.41M, up 57.51% year-over-year. In the year 2024, Vinci Compass Investments had annual revenue of 600.78M with 32.21% growth.

• Revenue (ttm): 726.41M BRL
• Revenue Growth: +57.51%
• P/S Ratio: 4.30
• Revenue / Employee: 2,977,102 BRL
• Employees: 244
• Market Cap: 599.56M USD

Revenue Chart

* This company reports financials in BRL.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	600.78M	146.36M	32.21%
Dec 31, 2023	454.42M	46.33M	11.35%
Dec 31, 2022	408.10M	-57.36M	-12.32%
Dec 31, 2021	465.46M	125.57M	36.94%
Dec 31, 2020	339.89M	43.18M	14.55%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.